MedicaidPrior AuthMedium impact
Palonosetron IV (Aloxi generics) (Revised)
Humana·OH · Oncology, Palliative Care, Critical Care +1 more·Medicaid
We identified it
Jul 2, 2026
Summary
Humana has revised its Prior Authorization policy for Palonosetron IV (Aloxi generics) for Ohio Medicaid members. This is a 1-day-old policy update that may affect prior authorization requirements, documentation, or coverage criteria for this anti-nausea medication. The billing team must review the full policy details to identify specific workflow changes.
Action Required
Immediately: Billing team must access the complete policy document at https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a56a5e2 to determine specific prior authorization requirements for Palonosetron IV (Aloxi generics) for Ohio Medicaid members. Update billing software, encounter forms, and staff training to reflect any new prior auth triggers, documentation requirements, or approval processes. Verify whether this policy supersedes any previous Palonosetron authorization guidance. Communicate changes to providers and clinical staff. Failure to comply with updated prior auth requirements will result in claim denials for Ohio Medicaid beneficiaries.